Algo version: 0.98b
Homology Medicines Inc is listed at the LSE Exchange
Homology Medicines Inc [0T6G.L]
LSE Sector: Healthcare Industry:Medical Pharmaceuticals

Is Homology Medicines Inc stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Homology Medicines Inc pays dividends. Last time was Thursday 1st of January 1970 where the investors holding the stock on Tuesday 15th of March 2022 were paid $0.0009 per share. Over the last 1 times between 2022 and 2022, Homology Medicines Inc has paid $0.0009 with an average of $0 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Homology Medicines Inc 10 years ago, but if you had invested on Thursday 25th of June 2020 when the price was $5 356.39, you would have made a loss of $-5 328.65 per share or -99.48%

No, the average daily trading liquidity for Homology Medicines Inc is $2 633 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Homology Medicines Inc has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. Homology Medicines Inc has a very good net profit margin of 443.47% and should have very high tolerances against inflation.

We have calculated the inflation risk for Homology Medicines Inc to be low [0.45 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.